Chenhao Xu
Overview
Explore the profile of Chenhao Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuan M, Wu Y, Zhou X, Cai Y, Li H, Xia A, et al.
Phytomedicine
. 2025 Feb;
139:156552.
PMID: 40020629
Background: Clematichinenoside AR (CAR) is an effective monomer component of Clematis chinensis Osbeck, which has therapeutic effects on rheumatoid arthritis (RA), but its specific mechanism is still not fully elucidated....
2.
Xu C, Fang X, Xu X, Wei X
Liver Res
. 2025 Feb;
8(3):131-140.
PMID: 39957748
Compared with the widely used rodents, pigs are anatomically, physiologically, and genetically more similar to humans, making them high-quality models for the study of liver diseases. Here, we review the...
3.
Yang Y, Hu Q, Shao Q, Peng Y, Yu B, Luo F, et al.
Adv Sci (Weinh)
. 2025 Jan;
12(10):e2410951.
PMID: 39840483
Osteoarthritis (OA) is increasingly recognized as a whole-organ disease predominantly affecting the elderly, characterized by typical alterations in subchondral bone and cartilage, along with recurrent synovial inflammation. Despite the availability...
4.
Xiang Z, Song Y, Li J, Yu J, Xu C, Xu Y, et al.
J Med Virol
. 2025 Jan;
97(1):e70150.
PMID: 39760308
Studies investigating the impact of donor cytomegalovirus (CMV) positivity on the prognosis of liver transplantation (LT) recipients with HCC are currently lacking. A total of 21 759 eligible LT recipients...
5.
Xu C, Su R, Lu Z, Song Y, Zhang X, Shu W, et al.
Genes Genomics
. 2024 Jul;
46(9):1045-1058.
PMID: 39078588
Background: The combination of Sorafenib and transcatheter arterial chemoembolization (TACE) exhibits limited efficacy in the treatment of certain advanced hepatocellular carcinomas (HCC), and the molecular mechanisms underlying resistance to this...
6.
Zhao J, Pan X, Wang Z, Chen Y, Liu D, Shen Y, et al.
Eur J Med Res
. 2024 Jul;
29(1):378.
PMID: 39033192
Background: A substantial proportion of patients with metastatic clear cell renal cell carcinoma (ccRCC) cannot derive benefit from immune checkpoint inhibitor (ICI) plus anti-angiogenic agent combination therapy, making identification of...
7.
Xu C, Fang X, Song Y, Xiang Z, Xu X, Wei X
Int J Biol Sci
. 2024 Jul;
20(9):3544-3556.
PMID: 38993564
Hepatic progenitor cells (HPCs) have a bidirectional potential to differentiate into hepatocytes and bile duct epithelial cells and constitute a second barrier to liver regeneration in the adult liver. They...
8.
Xie J, Li D, Niu S, Sheng Y, Shen R, He Y, et al.
Adv Healthc Mater
. 2024 Jun;
13(23):e2401009.
PMID: 38885692
Carbon nanotubes (CNTs) display good potential in tumor photothermal therapy (PTT). In this study, it is aimed to investigate the therapeutic potential of nano-titanium oxide-coated multi-walled carbon nanotubes (MCNTs) against...
9.
Xu B, Ji Y, Xu C, Zhang B, Liu K, Li J
Opt Express
. 2024 Jun;
32(8):13249-13265.
PMID: 38859300
Structured light 3D imaging systems commonly employ panel-based projectors or 1-axis MEMS mirrors with beam expander lens to project multi-frame barcodes or dot clouds, addressing challenges posed by objects with...
10.
Zhu Q, Chen J, Liu H, Zhao J, Xu C, Sun G, et al.
BMC Cancer
. 2024 Jun;
24(1):706.
PMID: 38851712
Background: Poly (ADP- ribose) polymerase inhibitors (PARPi) has been increasingly adopted for metastatic castration-resistance prostate cancer (mCRPC) patients with homologous recombination repair deficiency (HRD). However, it is unclear which PARPi...